Edition:
United States

Second Sight Medical Products Inc (EYES.OQ)

EYES.OQ on NASDAQ Stock Exchange Capital Market

1.57USD
10:57am EST
Change (% chg)

$0.01 (+0.64%)
Prev Close
$1.56
Open
$1.54
Day's High
$1.58
Day's Low
$1.54
Volume
5,924
Avg. Vol
125,177
52-wk High
$2.58
52-wk Low
$0.90

Latest Key Developments (Source: Significant Developments)

SECOND SIGHT RECEIVES FDA EXPEDITED ACCESS PATHWAY DESIGNATION FOR ORION SYSTEM
Wednesday, 8 Nov 2017 09:48am EST 

Nov 8 (Reuters) - Second Sight Medical Products Inc ::SECOND SIGHT RECEIVES FDA EXPEDITED ACCESS PATHWAY DESIGNATION FOR THE ORION CORTICAL VISUAL PROSTHESIS SYSTEM.ORION ALLOWS PATIENTS MORE TIMELY ACCESS TO MEDICAL DEVICES BY EXPEDITING DEVELOPMENT, ASSESSMENT, REVIEW .FDA HAS GRANTED EXPEDITED ACCESS PATHWAY DESIGNATION FOR ORION CORTICAL VISUAL PROSTHESIS SYSTEM​.  Full Article

Second Sight Medical Products reports Q3 loss per share $0.12
Thursday, 2 Nov 2017 04:00pm EDT 

Nov 2 (Reuters) - Second Sight Medical Products Inc :Second sight reports third quarter 2017 financial results.Q3 loss per share $0.12.Q3 sales $1.6 million versus $1.2 million.Second Sight Medical Products Inc - qtrly adjusted loss per share $0.11.  Full Article

Second Sight receives FDA approval to begin first Orion human clinical study
Thursday, 2 Nov 2017 08:05am EDT 

Nov 2 (Reuters) - Second Sight Medical Products Inc :Second Sight receives full FDA approval to begin first Orion human clinical study.Second sight-‍completed additional device testing, addressed remaining questions requested by FDA in prior conditional approval announced on Aug 28.Second Sight Medical Products Inc - ‍approval for Orion human clinical study allows two U.S. Sites to enroll up to five total patients​.  Full Article

Second Sight Medical Products files for mixed shelf of upto $100 mln‍​
Tuesday, 31 Oct 2017 06:16am EDT 

Oct 31 (Reuters) - Second Sight Medical Products Inc :Second Sight Medical Products Inc files for mixed shelf of upto $100 million - sec filing‍​.  Full Article

Second Sight receives conditional FDA approval to begin first Orion human clinical study
Monday, 28 Aug 2017 08:00am EDT 

Aug 28 (Reuters) - Second Sight Medical Products Inc :Second sight receives conditional FDA approval to begin first Orion human clinical study.Second sight medical products inc- ‍fda has also requested that company conduct additional device testing and address outstanding questions​.  Full Article

Second Sight Medical Products Q2 sales $2.2 mln
Tuesday, 1 Aug 2017 04:01pm EDT 

Aug 1 (Reuters) - Second Sight Medical Products Inc :Second Sight reports second quarter 2017 financial results.Q2 adjusted non-GAAP loss per share $0.12 excluding items.Q2 sales $2.2 million versus $1.0 million.Says total revenue was $2.2 million for q2 of 2017, compared with $1.0 million in q2 of 2016.  Full Article

Second Sight says Argus implant is available in Russia
Wednesday, 26 Jul 2017 08:30am EDT 

July 26 (Reuters) - Second Sight Medical Products Inc :Second sight announces market entry into russia with first implant of argus ii retinal prosthesis system.Second sight medical products inc - implant was facilitated by country's exclusive distribution partner, medical equipment trading company.  Full Article

Second Sight Medical Products submits application for IDE with FDA
Tuesday, 18 Jul 2017 06:49am EDT 

July 18 (Reuters) - Second Sight Medical Products Inc ::Second Sight Medical Products - submitted application for IDE with FDA for approval to conduct early feasibility study of orioncortical visual prosthesis system.Second Sight Medical Products - submitted application for approval to conduct an early feasibility study in a clinical trial of up to 5 patients.Second Sight Medical Products - IDE for approval to conduct feasibility study of orion cortical visual prosthesis system in clinical trial of up to 5 patients.  Full Article

Second Sight announces market entry into South Korea
Wednesday, 5 Jul 2017 08:00am EDT 

July 5 (Reuters) - Second Sight Medical Products Inc :Second sight announces market entry into south korea with two implants and performs second implant in taiwan of argus ii retinal prosthesis system.Second sight medical products inc says performs second implant in taiwan of argus ii retinal prosthesis system.  Full Article

Second Sight says Argus II can now be covered in seven of 12 MAC jurisdictions
Monday, 3 Jul 2017 08:00am EDT 

July 3 (Reuters) - Second Sight Medical Products Inc :Second sight announces expansion of medicare coverage for argus ii retinal prosthesis system to 11 additional states and the district of columbia.Second sight medical products inc - argus ii can now be covered in seven of 12 medicare administrative contractor jurisdictions.  Full Article

BRIEF-Second Sight Announces Market Entry Into Singapore With First Implant Of Argus II Retinal Prosthesis System

* SECOND SIGHT ANNOUNCES MARKET ENTRY INTO SINGAPORE WITH FIRST IMPLANT OF ARGUS II RETINAL PROSTHESIS SYSTEM Source text for Eikon: Further company coverage: